Tag: Blood Cancer
Gene Therapy offers Cure for Bubble Boy Syndrome
Severe combined immunodeficiency (SCID) or “Bubble Boy Syndrome” is a rare genetic disorder caused by gene mutations that inhibit the functioning of immune cells....
TG Therapeutics – Spearheading Innovations in Lymphoma Treatment
TG Therapeutics (NASDAQ: TGTX), a clinical stage company that is leading the innovation bandwagon in the field of novel therapies for B-cell malignancies and autoimmune...
MUSTANG BIO: SOARING TO A NEW HIGH AFTER BUBBLE BOY CURE...
Mustang Bio’s (NASDAQ: MBIO) shares rose by almost 250% after its development partner, St Jude Children’s Research Hospital in Memphis, published study results that...
We are looking for talented interns to learn and help investors find valuable companies.